FDA Inspection 1181929 — Biomat USA, Inc.
The FDA completed an inspection of Biomat USA, Inc. on Oct 14, 2022 in Carrollton, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 14, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Carrollton, TX (United States)